Cross-sectional study identifies gender-affirming care costs in transgender youths, suggesting healthcare disparities exist.
This cross-sectional study identifies the nationwide utilization rates and costs of gender-affirming hormone therapy, puberty blockers, and surgical procedures among transgender and gender-diverse youths in the US.
No takes yet. Share an insight, caveat, or question.
Jiro Maeda (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: